These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20132502)

  • 41. Benefit of converting enzyme inhibition on left ventricular volumes and ejection fraction in patients receiving beta-blockade after myocardial infarction. CONSENSUS II multiecho study group.
    Bonarjee VV; Carstensen S; Caidahl K; Nilsen DW; Edner M; Lindvall K; Snapinn SM; Berning J
    Am Heart J; 1996 Jul; 132(1 Pt 1):71-7. PubMed ID: 8701878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of beta blocker therapy on survival of patients with heart failure and preserved systolic function following hospitalization with acute decompensated heart failure.
    Nevzorov R; Porath A; Henkin Y; Kobal SL; Jotkowitz A; Novack V
    Eur J Intern Med; 2012 Jun; 23(4):374-8. PubMed ID: 22560389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease.
    Allen LaPointe NM; Zhou Y; Stafford JA; Hernandez AF; Kramer JM; Anstrom KJ
    Am J Cardiol; 2009 Jun; 103(11):1518-24. PubMed ID: 19463509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term prescription of beta-blocker delays the progression of heart failure with preserved ejection fraction in patients with hypertension: A retrospective observational cohort study.
    Gu J; Fan YQ; Bian L; Zhang HL; Xu ZJ; Zhang Y; Chen QZ; Yin ZF; Xie YS; Wang CQ
    Eur J Prev Cardiol; 2016 Sep; 23(13):1421-8. PubMed ID: 26915580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.
    Verbrugge FH; Duchenne J; Bertrand PB; Dupont M; Tang WH; Mullens W
    Am J Cardiol; 2013 Dec; 112(12):1913-20. PubMed ID: 24286620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term effect of β-blocker in ST-segment elevation myocardial infarction in patients with preserved left ventricular systolic function: a propensity analysis.
    Konishi H; Miyauchi K; Kasai T; Tsuboi S; Ogita M; Naito R; Nishizaki Y; Okai I; Tamura H; Okazaki S; Isoda K; Daida H
    Heart Vessels; 2016 Apr; 31(4):441-8. PubMed ID: 25573259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Managing the post-myocardial infarction patient with asymptomatic left ventricular dysfunction.
    Philippides GJ
    Cardiology; 2006; 105(2):95-107. PubMed ID: 16340202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of β-blockers on left ventricular remodeling in patients with preserved ejection fraction after acute myocardial infarction.
    Horiuchi Y; Tanimoto S; Aoki J; Nakajima H; Hara K; Tanabe K
    Int J Cardiol; 2016 Oct; 221():765-9. PubMed ID: 27428318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta-blocker initiation and adherence after hospitalization for acute myocardial infarction.
    Maio V; Marino M; Robeson M; Gagne JJ
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):438-45. PubMed ID: 21450641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
    Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
    JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of different beta-blockers on left-ventricular volume and function after primary coronary stenting in acute myocardial infarction.
    Lee SH; Yoon SB; Cho JR; Choi S; Jung JH; Lee N
    Angiology; 2008 Dec-2009 Jan; 59(6):676-81. PubMed ID: 18388053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Captopril adjuvant therapy to beta-blockers and nitrates improves post-myocardial infarction left ventricular performance.
    Kyriakidis M; Antonopoulos A; Georgiou E; Santas P; Bakirtzis C; Toutouzas P
    Eur Heart J; 1996 Jun; 17(6):864-73. PubMed ID: 8781825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
    Bang CN; Greve AM; Køber L; Rossebø AB; Ray S; Boman K; Nienaber CA; Devereux RB; Wachtell K
    Int J Cardiol; 2014 Aug; 175(3):492-8. PubMed ID: 25012498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
    Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
    Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between changes in heart rate recovery after cardiac rehabilitation on cardiovascular mortality in patients with myocardial infarction.
    Hai JJ; Siu CW; Ho HH; Li SW; Lee S; Tse HF
    Heart Rhythm; 2010 Jul; 7(7):929-36. PubMed ID: 20346416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction.
    Lowrie R; Mair FS; Greenlaw N; Forsyth P; Jhund PS; McConnachie A; Rae B; McMurray JJ;
    Eur Heart J; 2012 Feb; 33(3):314-24. PubMed ID: 22083873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial.
    Bangalore S; Bhatt DL; Steg PG; Weber MA; Boden WE; Hamm CW; Montalescot G; Hsu A; Fox KA; Lincoff AM
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):872-81. PubMed ID: 25271049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of cardiac disease severity in the predictive value of anxiety for all-cause mortality.
    Meyer T; Buss U; Herrmann-Lingen C
    Psychosom Med; 2010 Jan; 72(1):9-15. PubMed ID: 19995887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Angiotensin Receptor Blocker Dose in Myocardial Infarction With Preserved Left Ventricular Systolic Function.
    Kim HY; Mok J; Kim JY; Jeon D; Her SH; Park MW; Kim DB; Park CS; Lee JM; Chang K; Jung WS; Ahn Y
    J Cardiovasc Pharmacol; 2023 Jul; 82(1):52-60. PubMed ID: 37019077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin-converting enzyme inhibitor therapy affects left ventricular mass in patients with ejection fraction > 40% after acute myocardial infarction.
    Johnson DB; Foster RE; Barilla F; Blackwell GG; Roney M; Stanley AW; Kirk K; Orr RA; van der Geest RJ; Reiber JH; Dell'Italia LJ
    J Am Coll Cardiol; 1997 Jan; 29(1):49-54. PubMed ID: 8996294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.